the 2Q/2023 financial statements as of August 31, 2023 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview
the 3Q/2023 financial statements as of November 30, 2023 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview
fiscal year 2023 financial statements ended February 29, 2024 which were audited by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized as follows. Overview
working capital. Tax Expenses Income tax expense increased from THB 12.2 Mn in 9M17 to THB 25.1 Mn in 9M18, an increase of THB 12.8 Mn. This was mostly due higher profit from Japanese and Thai restaurants
period from financial institutions for use as working capital. Tax Expenses Income tax expense increased from THB 12.2 Mn in 2017 to THB 25.1 Mn in 2018 respectively, an increase of THB 12.8 Mn or 104.9
informed accordingly. Yours Sincerely, (Mr. Chih - Hung Lin) Chief Operating Officer Contact: Company Secretary Office Tel: 0 2658 8881 บรษิทัหลกัทรพัย ์เคจีไอ (ประเทศไทย) จํากดั )มหาชน( 173 อาคารเอเซีย เซ็น
operated. However, the ratio of net loss to revenues from medical services decreased compared year 2016 from 24.01% to 15.45% in year 2017, presenting the better operating performance. Summary of Financial
between the Company, existing shareholders who intend to dispose their shares, and Phoenix. Source of Fund : Working Capital Number of Board of Directors in Phoenix after acquisition : After share
762,160,000 baht (according to the appraisal report of Sasirachada Company Limited on 1 October 2019.) 6. Source of Funding Internal Working Capital 7. Valuation of the investment Par value of ordinary shares
Limited on 1 October 2019.) 6. Source of Funding Internal Working Capital and received a refund of capital from a subsidiary company which is in the process of liquidation 7. Valuation of the investment Par